GFAP and Alzheimer disease: Elevated GFAP levels in CSF and plasma have been observed across multiple neurological conditions, including AD, Parkinson’s disease, Huntington’s disease, traumatic brain injury (TBI), stroke, multiple sclerosis, neuromyelitis optica spectrum disorder, cerebral amyloid angiopathy, and prion disease [111–119].